The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
As states grapple with a shortage of coronavirus vaccines, the Centre on Thursday said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.
This may include Rs 1,500 as a screening test for suspect cases and an additional Rs 3,000 for confirmation test, the guidelines said.
As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.
DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
The first two coaches that rolled out from the Railway Coach Factory in Kapurthala also have fixtures coated with titanium dioxide and the provision for plasma air equipment in AC ducts to sterilise interiors using ionised air. Railway Minister Piyush Goyal also indicated that the new coaches could be the new normal.
Data also show that several other leading domestic pharma companies have recalled their products from the US
Overall, the credit profiles of players will be supported by healthy balance sheets and liquidity. Prudence in capital and development expenditure, efficient working-capital management, and recent equity raising will help sustain credit metrics in FY22.
Soon after Trump revealed to the world that he has been taking the medicine, the White House doctor said the president is in good health.
'Nobody is attacking the company or the vaccine.' 'The concerns are about the process and the lack of transparency.'
FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.
Maggi noodles was recalled in June because some states had found presence of MSG and excessive lead content in the samples.
Sun Pharma's acquisition of Ranbaxy has once again revived evaluation of the troubled past of the latter, which had changed hands from the promoters merely five years ago.
The move follows an FDA inspection of a Ranbaxy facility which identified significant violations of sound manufacturing practices.
the Maharashtra Food and Drug Administration on Saturday issued directives to various departments to cancel the licences of gutkha manufacturers, wholesalers and retailers in the state after finding magnesium carbonate in gutkha.
The US market for the drug is pegged at $1 billion. Cipla has been selling the product in the European market. It had won a similar case in the UK against GSK a couple of years ago.
Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.
For Sun Pharma, it is an astute purchase that it hopes will not only boost its position in India but also globally.
The move comes after a FDA notice to gutkha manufacturers to mention the contents of their product on the cover.
These drugs will be entering in their global Phase -3 clinical trials early next year.
The Oxford/AstraZeneca vaccine is also being produced as part of a tie-up by the Serum Institute of India.
'We built it in the last three years and then one day, they came and they said you have to close it'
The Japanese company alleges the earlier Ranbaxy promoters withheld crucial information when they sold the company in 2008.
After recovering from issues such as defaults on foreign currency convertible bonds and piling debts, pharmaceutical major Wockhardt has been on the slow lane through the last six months, following warnings from global regulators such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare Products Regulatory Agency.
The pain relieving balm is made available at more than 1,000 retail stores in 75 different cities in 12 states in India
The tests, according to the report, showed that Pepsi products from its plant in Khalapur in Raigad district contained 0.6 mg of lindane, which is above the permissible limits.
The outcome reaffirms the company's own testing and the long-standing assurance it gave that its baby shampoo does not contain formaldehyde or any formaldehyde-releasing ingredients, J&J said.
Amrita Singh scours the market for the smartest health devices going.
A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.
Singh brothers might be stopped by 'fit & proper' hurdle due to US drug norm violations; firm says confident of qualifying.
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
After Maggi, the sample of macroni pasta was taken from Mau and sent to National Food Analysis Laboratory.
The Maharashtra Food and Drugs Administration has initiated action against manufacturers of medicines and instruments, newspapers, TV channels and cable operators making outrageous claims through advertisements.
There are also lingering concerns over the culture of misuse of pharmaceutical products in India, which has, in the past, led to other drugs becoming increasingly ineffective.
Through a Freedom of Information Act request, the Show '20/20' obtained lists of recent health violation records from the FDA, the agency in charge of inspecting airlines and their outside food caterers.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances